首页> 外文OA文献 >PRM228 - EXTRAPOLATION OF SURVIVAL CURVES USING EXTERNAL INFORMATION: IMPLEMENTATION OF GUYOT’S METHOD IN PREVIOUSLY UNTREATED ADVANCED OR METASTATIC RENAL CELL CARCINOMA

【2h】

PRM228 - EXTRAPOLATION OF SURVIVAL CURVES USING EXTERNAL INFORMATION: IMPLEMENTATION OF GUYOT’S METHOD IN PREVIOUSLY UNTREATED ADVANCED OR METASTATIC RENAL CELL CARCINOMA

机译：PRM228 - 使用外部信息外推生存曲线：在以前未经治疗的先进或转移性肾细胞癌中实现征收的方法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
H Cawston; V Genestier; P Dale; J Doan; B Malcolm;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model [J] . Chrom Pawel, Zolnierek Jakub, Bodnar Lubomir, International journal of clinical oncology . 2019,第5期

机译：全身免疫炎症指数的外部验证作为转移性肾细胞癌的预后因素及其在国际转移性肾细胞癌数据库中的实施
2. Early Completion of Phase-III-Study CheckMate-214: Nivolumab in Combination with Ipilimumab shows an Overall Survival Benefit in Patients with previously untreated advanced or metastatic Renal Cell Carcinoma [J] . Oncology research and treatment. . 2017,第11期

机译：早期完成期 - III研究的checkmate-214：Nivolumab与Ipilimumab的组合显示出先前未经处理的先进或转移性肾细胞癌患者的整体存活益处
3. A new prognostic classification for overall survival in asian patients with previously untreated metastatic renal cell carcinoma [J] . ShinoharaN., NonomuraK., AbeT., Cancer science. . 2012,第9期

机译：亚洲先前未接受治疗的转移性肾细胞癌患者总体生存的新预后分类
4. Integration of Surgery and Systemic Therapy in the Treatment of Locally Advanced and Metastatic Renal Cell Carcinoma [C] . Christopher G. Wood Genitourinary Cancers Symposium . 2011

机译：外科和全身治疗在局部晚期和转移性肾细胞癌中的整合
5. Methodological Approaches for Conducting Claims-Based Studies in Patients Diagnosed with Metastatic Renal Cell Carcinoma [D] . Chun, Danielle S. 2021

机译：用于诊断转移性肾细胞癌的患者的基于权利要求的基于权利要求的方法论方法
6. Survival and clinical prognostic factors in metastatic non‐clear cell renal cell carcinoma treated with targeted therapy: A multi‐institutional retrospective study using the Korean metastatic renal cell carcinoma registry [O] . Jung Kwon Kim, Sung Han Kim, Mi Kyung Song, 2019

机译：靶向治疗治疗的转移性非透明细胞肾细胞癌的生存和临床预后因素：使用韩国转移性肾细胞癌登记系统的多机构回顾性研究
7. PUK9 - NETWORK META-ANALYSIS OF TREATMENTS IN PREVIOUSLY UNTREATED ADVANCED OR METASTATIC RENAL-CELL CARCINOMA WITH INTERMEDIATE TO POOR PROGNOSIS [O] . V.A. Laliman, X. Wang, H. Cawston, 2018

机译：PUK9 - 网络间分析以前未经处理的先进或转移性肾细胞癌的治疗分析，中间体预后差

PRM228 - EXTRAPOLATION OF SURVIVAL CURVES USING EXTERNAL INFORMATION: IMPLEMENTATION OF GUYOT’S METHOD IN PREVIOUSLY UNTREATED ADVANCED OR METASTATIC RENAL CELL CARCINOMA

著录项

引文网络

相似文献

相关主题

期刊订阅